Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

342 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy of immune checkpoint inhibitors plus platinum-based chemotherapy as 1st line treatment for patients with non-small cell lung cancer harboring HER2 mutations: Results from LC-SCRUM-Asia.
Kato Y, Udagawa H, Matsumoto S, Izumi H, Ohe Y, Kato T, Nishino K, Miyamoto S, Kawana S, Chikamori K, Shingyoji M, Sato Y, Takada Y, Toyozawa R, Azuma K, Tanaka Y, Sakai T, Shibata Y, Sugiyama E, Nosaki K, Zenke Y, Umemura S, Yoh K, Seike M, Goto K. Kato Y, et al. Among authors: kawana s. Lung Cancer. 2024 Nov;197:107992. doi: 10.1016/j.lungcan.2024.107992. Epub 2024 Oct 13. Lung Cancer. 2024. PMID: 39423763
Durvalumab with etoposide and carboplatin for patients with extensive-stage small cell lung cancer and interstitial lung disease: A multicenter, open-label prospective trial.
Shibaki R, Fujimoto D, Miyauchi E, Tsukita Y, Nakachi I, Arai D, Sakata Y, Shingu N, Shimokawa T, Kijima T, Tamiya M, Kawana S, Hara S, Saito G, Sato Y, Yokoyama T, Sakata S, Taniguchi Y, Hata A, Matsumoto H, Yamaguchi T, Yamamoto N. Shibaki R, et al. Among authors: kawana s. Lung Cancer. 2024 Oct;196:107958. doi: 10.1016/j.lungcan.2024.107958. Epub 2024 Sep 19. Lung Cancer. 2024. PMID: 39312871 Clinical Trial.
In vivo lung perfusion for prompt recovery from primary graft dysfunction after lung transplantation.
Matsubara K, Miyoshi K, Kawana S, Kubo Y, Shimizu D, Tomioka Y, Shiotani T, Yamamoto H, Tanaka S, Kurosaki T, Ohara T, Okazaki M, Sugimoto S, Matsukawa A, Toyooka S. Matsubara K, et al. Among authors: kawana s. J Heart Lung Transplant. 2024 Feb;43(2):284-292. doi: 10.1016/j.healun.2023.10.011. Epub 2023 Oct 16. J Heart Lung Transplant. 2024. PMID: 37852513
Efficacy of paclitaxel-carboplatin with bevacizumab as a late-line therapy for patients with advanced nonsquamous non-small cell lung cancer: A platinum rechallenge.
Sugisaka J, Toi Y, Kawashima Y, Domeki Y, Aiba T, Kawana S, Nakamura A, Yamanda S, Kimura Y, Sugawara S. Sugisaka J, et al. Among authors: kawana s. Thorac Cancer. 2023 Nov;14(31):3140-3146. doi: 10.1111/1759-7714.15107. Epub 2023 Sep 12. Thorac Cancer. 2023. PMID: 37699787 Free PMC article.
S100A8/A9 as a prognostic biomarker in lung transplantation.
Nakata K, Okazaki M, Kawana S, Kubo Y, Shimizu D, Tanaka S, Hashimoto K, Suzawa K, Shien K, Miyoshi K, Yamamoto H, Sugimoto S, Toyooka S. Nakata K, et al. Among authors: kawana s. Clin Transplant. 2023 Sep;37(9):e15006. doi: 10.1111/ctr.15006. Epub 2023 Apr 28. Clin Transplant. 2023. PMID: 37115007
342 results